• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,470.11 -238.41
( -0.31%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,580.59 55.83
(0.53%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Container Corporation Of India Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
531344
INE111A01025
169.2412741
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCOR
31.09
37981.89
EPS(TTM)
Face Value()
Div & Yield %
16.04
5
0.88
 

Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter
May 30,2026
Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 8.14% to Rs 42.24 crore in the quarter ended March 2026 as against Rs 39.06 crore during the previous quarter ended March 2025.

For the full year,net profit rose 167.47% to Rs 11.10 crore in the year ended March 2026 as against Rs 4.15 crore during the previous year ended March 2025. Sales rose 3.26% to Rs 150.62 crore in the year ended March 2026 as against Rs 145.86 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales42.2439.06 8 150.62145.86 3
OPM %8.407.96 -10.587.66 -
PBDT4.283.32 29 17.0411.19 52
PBT2.623.10 -15 10.976.30 74
NP2.751.31 110 11.104.15 167